A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder - Contacts and Locations

A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder

This study has been completed.

Study NCT00555139. Last updated on October 15, 2008. Information provided by GlaxoSmithKline

Please refer to this study by its ClinicalTrials.gov identifier: NCT00555139

Locations


Spain
	GSK Investigational Site
	Barcelona, Spain, 08025
	GSK Investigational Site
	Sabadell (Barcelona), Spain, 08208
	GSK Investigational Site
	Terrassa - Barcelona, Spain, 08227
	GSK Investigational Site
	Barcellona, Spain, 08025
	GSK Investigational Site
	Hospitalet de Llobregat, Spain, 08907
	GSK Investigational Site
	Mataro (Barcelona), Spain
	GSK Investigational Site
	Barcelona, Spain, 08035
	GSK Investigational Site
	Barcelona, Spain
	GSK Investigational Site
	Barcelona, Spain, E-08003

Sponsors and Collaborators

GlaxoSmithKline

Investigators


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline